KLF4 mediates the effects of mesalazine, also known as 5-aminosalicylic acid (5-ASA), an aminosalicylate anti-inflammatory drug [21], on the β-catenin pathway in colon cancer cells. This evidence concerns the gene KLF4 and colonic neoplasm.